Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Part 11 guidance withdrawn

This article was originally published in The Tan Sheet

Executive Summary

FDA guidance on submission of electronic records withdrawn Feb. 3, as it "may no longer represent FDA's approach under the [current good manufacturing practice] initiative." Agency "wishes to limit the time spent by industry" reviewing the guidance, which was published in recent Federal Register (1"The Tan Sheet" Nov. 11, 2002, In Brief). FDA "may decide to reissue the draft guidance once it has reviewed it under the cGMP initiative"...

Related Content

Electronic Records Enforcement Relaxed During Part 11 Review, FDA Says
Part 11 guidance





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts